Concepedia

Catherine Cheng

CC

Statistics

Publications

14

Citations

789

H-Index

12

Active since

2017

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

The University of Texas Health Science Center at San Antonio

South Texas Veterans Health Care System

Levine Cancer Institute

Catherine Cheng is an author at University of North Carolina at Chapel Hill specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2017–2024

14

Publications

14

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Carlos A. Ramos, Natalie S. Grover, Anne Beaven et al. · Journal of Clinical Oncology · 2020 · 366 citations · Full text

Utility of a safety switch to abrogate CD19.CAR T-cell–associated neurotoxicity

Matthew C. Foster, Barbara Savoldo, Winnie Lau et al. · Blood · 2021 · 66 citations · Full text

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Randy Strong, Richard A. Miller, Catherine Cheng et al. · Aging Cell · 2022 · 60 citations · Full text

, , +20

Genetically heterogeneous mice exhibit a female survival advantage that is age‐ and site‐specific: Results from a large multi‐site study

Catherine Cheng, Jonathan Gelfond, Randy Strong et al. · Aging Cell · 2019 · 48 citations · Full text

Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma

Timothy Voorhees, Beibo Zhao, Jorge D. Oldan et al. · Blood Advances · 2021 · 45 citations · Full text

, , +15

1–5 of 14